Crossmark

EGFR-targeting polydopamine nanoparticles co-loaded with 5-fluorouracil, irinotecan, and leucovorin to potentially enhance metastatic colorectal cancer therapy

Crossref DOI link: https://doi.org/10.1038/s41598-024-80879-0

Published Online: 2024-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Djermane, Rania

Nieto, Celia

Vega, Milena A.

del Valle, Eva M. Martín
Funding

Funding for this research was provided by:

Universidad de Salamanca (PIC2-2021-19)

Ministerio de Ciencia e Innovación (PID2022-140599OB-I00)
License Information

Text and Data Mining valid from 2024-11-26

Version of Record valid from 2024-11-26
More Information

Article History

Received: 26 March 2024

Accepted: 22 November 2024

First Online: 26 November 2024

Declarations

:

: The authors declare no competing interests.

: Not applicable.

Document is current

Any future updates will be listed below